Does Rallies show REPL price targets?

Yes. Rallies tracks REPL analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.

Is REPL research on Rallies investment advice?

No. Rallies provides research, data, and educational context for REPL. It does not provide personalized investment advice.

REPL (Replimune Group, Inc.) Stock Analysis - Analyst Ratings

Replimune Group, Inc. (REPL) is a publicly traded Healthcare sector company. As of October 22, 2026, REPL trades at $11.73 with a market cap of $1.08B and a P/E ratio of -3.89. REPL moved +0.09% today. Year to date, REPL is +20.58%; over the trailing twelve months it is +31.02%. Its 52-week range spans $1.50 to $16.33. Analyst consensus is strong buy with an average price target of $19.14. Rallies surfaces REPL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate REPL?

8 analysts cover REPL: 0 strong buy, 8 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $19.14.

REPL Key Metrics

Key financial metrics for REPL
Metric	Value
Price	$11.73
Market Cap	$1.08B
P/E Ratio	-3.89

EPS	$-3.38

Dividend Yield	0.00%

52-Week High	$16.33

52-Week Low	$1.50

Volume	26.25K

Avg Volume	0

Revenue (TTM)	$0

Net Income	$-313.94M

Gross Margin	0.00%

Common questions about REPL

What do analysts rate REPL?: 8 analysts cover REPL: 0 strong buy, 8 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $19.14.
Does Rallies show REPL price targets?: Yes. Rallies tracks REPL analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is REPL research on Rallies investment advice?: No. Rallies provides research, data, and educational context for REPL. It does not provide personalized investment advice.

Replimune Group

Analysts

Replimune Group

Analysts

REPL Analyst Consensus

Common questions about REPL